Aa
Aa
A
A
A
Close
667078 tn?1316000935

Shared Solution is Stupid Solutions

With all I have been put through with Shared Solutions, they called me again inviting me to sign up for the DISCOUNT PROGRAM.

Then they say you applied but you are not eligible.

I asked why when you know I am not eligible do you call me all the time offering me the discount and get me upset again. Are you just sadistic?  It says on the computer I am not eligible.

I had a bad reaction to Copaxone last night but I sure was not going to call these idiots.

Alex
3 Responses
Sort by: Helpful Oldest Newest
572651 tn?1530999357
Alex,
I can't be of help with SS and their crazy solicitations.  But I might suggest that you play with the adjustment on your autoinject and see if the reactions calm down.  Many here even just do the injection without the pen, but not me.  

I hope tomorrow goes better,
Lulu
Helpful - 0
559187 tn?1330782856
Ditto with what Shell just asked....What reaction did you have?  You know we both are looking out for each other with these copaxone shots so, what happened?  

Julie
Helpful - 0
198419 tn?1360242356
Shoot, I just commented on your 1st post on this, not reading this and finding it's going from bad to worse.

What was the reaction?
Helpful - 0
Have an Answer?

You are reading content posted in the Multiple Sclerosis Community

Top Neurology Answerers
987762 tn?1671273328
Australia
5265383 tn?1669040108
ON
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease